These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 7316395

  • 1. [Darier's disease and renal polycystosis. Familial study and effects of aromatic retinoid].
    Claudy A, Toulon J, Dutoit M, Sabatier JC, Berthoux FC.
    Ann Dermatol Venereol; 1981; 108(8-9):675-7. PubMed ID: 7316395
    [No Abstract] [Full Text] [Related]

  • 2. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J.
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of dyskeratosis follicularis Darier with the retinoic acid derivative Ro 10-9359 (Tigason).
    Christiansen JV, Holm P, Møller R, Reymann F, Schmidt H.
    Dermatologica; 1981; 163(2):164-8. PubMed ID: 7286356
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
    Burge SM, Wilkinson JD, Miller AJ, Ryan TJ.
    Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of follicular dyskeratosis (Darier's disease) with aromatic vitamin A].
    Mária W, Miklós S.
    Orv Hetil; 1981 Mar 01; 122(9):522-4. PubMed ID: 7290698
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
    Pehamberger H, Esca SA, Holubar K.
    Z Hautkr; 1980 Jan 15; 55(2):68-78. PubMed ID: 7405336
    [Abstract] [Full Text] [Related]

  • 7. Histochemical study of enzyme activities during etretinate treatment of Darier's disease.
    Löwhagen GB, Mobacken H, Heyden G.
    Dermatol Monatsschr; 1982 Nov 15; 168(11):733-9. PubMed ID: 6897639
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of Darier's disease with an oral aromatic retinoid (Ro 10-9359): a clinical and light and electron microscopic study.
    Lauharanta J, Niemi KM, Lassus A.
    Acta Derm Venereol; 1981 Nov 15; 61(6):535-42. PubMed ID: 6177166
    [Abstract] [Full Text] [Related]

  • 9. Excessive cerumen production due to the aromatic retinoid Tigason in a patient with Darier's disease.
    Kramer M.
    Acta Derm Venereol; 1982 Nov 15; 62(3):267-8. PubMed ID: 6179378
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of dyskeratosis follicularis (Darier's disease) with aromatic retinoid].
    Rubisz-Brzezińska J.
    Przegl Dermatol; 1987 Nov 15; 74(6):443-8. PubMed ID: 3330247
    [No Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of a new oral retinoid RO10 9359 in the treatment of Darier's disease.
    Watson AB.
    Australas J Dermatol; 1980 Aug 15; 21(2):76-8. PubMed ID: 7447813
    [No Abstract] [Full Text] [Related]

  • 12. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
    Greig DE, Wishart J, Hodge JL.
    N Z Med J; 1981 Aug 12; 94(689):99-100. PubMed ID: 6944653
    [Abstract] [Full Text] [Related]

  • 13. [Dermatoses difficult to treat. Their treatment with an aromatic retinoid (etretinate)].
    Solano E, Hidalgo H.
    Med Cutan Ibero Lat Am; 1983 Aug 12; 11(5):369-71. PubMed ID: 6230492
    [Abstract] [Full Text] [Related]

  • 14. [Dyskeratosis follicularis vegetans (Darier disease)--therapy with the aromatic retinoid RO 10-9359 (Tigason) in combination with systemic photochemotherapy (RePUVA)].
    Sönnichsen N, Brenke A, Diezel W.
    Dermatol Monatsschr; 1982 Aug 12; 168(8):520-2. PubMed ID: 7173474
    [No Abstract] [Full Text] [Related]

  • 15. Effects of etretinate (Ro 10-9359) on Darier's Disease.
    Löwhagen GB, Michaëlsson G, Mobacken H, Pettersson U, Vahlquist A.
    Dermatologica; 1982 Aug 12; 165(2):123-30. PubMed ID: 7141063
    [Abstract] [Full Text] [Related]

  • 16. [Hyperkeratotic variant of Darier's disease. Successful oral treatment using an aromatic retinoid (Ro 10-9395)].
    Hönigsmann H, Fritsch P, Jaschke E.
    Hautarzt; 1978 Nov 12; 29(11):601-3. PubMed ID: 721466
    [Abstract] [Full Text] [Related]

  • 17. A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease.
    Christophersen J, Geiger JM, Danneskiold-Samsoe P, Kragballe K, Larsen FG, Laurberg G, Serup J, Thomsen K.
    Acta Derm Venereol; 1992 Nov 12; 72(2):150-2. PubMed ID: 1350407
    [Abstract] [Full Text] [Related]

  • 18. Darier's Disease Complicated by Schizophrenia Caused by a Novel ATP2A2 Mutation.
    Takeichi T, Sugiura K, Nakamura Y, Fujio Y, Konohana I, Akiyama M.
    Acta Derm Venereol; 2016 Nov 02; 96(7):993-994. PubMed ID: 27025976
    [No Abstract] [Full Text] [Related]

  • 19. [The therapeutic efficacy of tigazon in treating dermatoses].
    Skripkin IuK, Korotkiĭ NG, Udzhukhu VIu, Kriazheva SS, Butov IuS.
    Vestn Dermatol Venerol; 1990 Nov 02; (5):4-6. PubMed ID: 2402940
    [Abstract] [Full Text] [Related]

  • 20. Clinical and ultrastructural effects of acitretin in Darier's disease.
    Lauharanta J, Kanerva L, Turjanmaa K, Geiger JM.
    Acta Derm Venereol; 1988 Nov 02; 68(6):492-8. PubMed ID: 2467487
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.